We are live on ! Find out more
NUVB icon

Nuvation Bio
NUVB

231 hedge funds and large institutions have $947M invested in Nuvation Bio in 2026 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 90 increasing their positions, 58 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 58

45% more call options, than puts

Call options by funds: $5.27M | Put options by funds: $3.64M

27% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 37

4% more funds holding

Funds holding: 223 → 231 (+8)

1.92% more ownership

Funds ownership: 61.7% → 63.62% (+1.9%)

44% less funds holding in top 10

Funds holding in top 10: 9 → 5 (-4)

50% less capital invested

Capital invested by funds: $1.89B → $947M (-$948M)

Holders
231
Holders Change
+8
Holders Change %
+3.59%
% of All Funds
2.84%
Holding in Top 10
5
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-44.44%
% of All Funds
0.06%
New
47
Increased
90
Reduced
58
Closed
37
Calls
$5.27M
Puts
$3.64M
Net Calls
+$1.63M
Net Calls Change
-$24.5M

Top Buyers

1
DFO
Duquesne Family Office
New York
+$25.3M
2
American Century Companies
American Century Companies
Missouri
+$15.9M
3
Two Sigma Investments
Two Sigma Investments
New York
+$10.9M
4
Citadel Advisors
Citadel Advisors
Florida
+$10.8M
5
AG
Algert Global
California
+$8.64M

Top Sellers

1
CFM
Capricorn Fund Managers
United Kingdom
-$14.2M
2
ACM
Abrams Capital Management
Massachusetts
-$14.2M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$13.4M
4
N
Nuveen
North Carolina
-$13M
5
SCP
SymBiosis Capital Partners
Arkansas
-$11.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
26
Armistice Capital
New York
$7.45M +$2.63M +472,263 +37%
VFT
27
Vanguard Fiduciary Trust
Pennsylvania
$6.83M +$8.87M +1,592,449 New
KCM
28
Knoll Capital Management
Florida
$6.43M – – –
Arrowstreet Capital
29
Arrowstreet Capital
Massachusetts
$6.17M +$3.45M +619,725 +76%
UBS Group
30
UBS Group
Switzerland
$5.89M +$4.23M +758,545 +123%
ACM
31
Abrams Capital Management
Massachusetts
$5.45M -$14.2M -2,541,009 -67%
Connor, Clark & Lunn Investment Management (CC&L)
32
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$5.18M +$5.66M +1,015,773 +529%
Millennium Management
33
Millennium Management
New York
$4.81M +$2.29M +410,636 +58%
NA
34
NewEdge Advisors
Louisiana
$4.42M +$440K +78,946 +8%
WP
35
Woodline Partners
California
$4.12M +$13.9K +2,500 +0.3%
TCM
36
Tanaka Capital Management
New York
$3.87M +$335K +60,220 +7%
SAM
37
Silvercrest Asset Management
New York
$3.11M +$4.04M +724,383 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$2.93M -$20.8K -3,731 -0.5%
Wellington Management Group
39
Wellington Management Group
Massachusetts
$2.88M -$1.27M -227,844 -25%
BPA
40
Beacon Pointe Advisors
California
$2.76M +$2.14M +384,522 +148%
Man Group
41
Man Group
United Kingdom
$2.71M +$3.52M +632,238 New
Renaissance Technologies
42
Renaissance Technologies
New York
$2.4M +$3.12M +559,180 New
N
43
Nuveen
North Carolina
$2.21M -$13M -2,337,884 -82%
UBS AM
44
UBS AM
Illinois
$2.2M -$49.5K -8,877 -2%
JP Morgan Chase
45
JP Morgan Chase
New York
$2.18M -$311K -55,883 -9%
PAI
46
Palo Alto Investors
California
$2.18M -$163K -29,233 -5%
AllianceBernstein
47
AllianceBernstein
Tennessee
$2.13M +$46.9K +8,414 +4%
GCP
48
GSA Capital Partners
United Kingdom
$2.13M +$2.68M +481,681 +3,414%
HWAM
49
Hennion & Walsh Asset Management
New Jersey
$1.93M +$29.6K +5,315 +1%
Invesco
50
Invesco
Georgia
$1.88M -$4.16M -747,337 -63%
1
2
3 4 5

NUVB Hedge Fund Activity: Q1 2026 in Review

231 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q1 2026, worth a combined $947M — down 50% from $1.89B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new NUVB positions and 37 closed out — a net gain of 10 holders — while 90 added to existing stakes and 58 trimmed.

The largest buyer was Duquesne Family Office, opening a new position worth an estimated $25.3M. The largest seller was Capricorn Fund Managers, exiting entirely with an estimated $14.2M sold.

  • 231 institutional investors held Nuvation Bio (NUVB) as of Q1 2026, up from 223 in Q4 2025.
  • Funds reported $947M of Nuvation Bio stock for Q1 2026, down 50% quarter-over-quarter.
  • 47 funds opened new Nuvation Bio positions in Q1 2026 and 37 closed out, a net change of +10 holders.
  • The largest Nuvation Bio buyer in Q1 2026 was Duquesne Family Office, an estimated $25.3M added.
  • The largest Nuvation Bio seller in Q1 2026 was Capricorn Fund Managers, an estimated $14.2M sold.

Based on aggregated 13F filings for Q1 2026.